Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast
Azenta (Nasdaq: AZTA) has scheduled its fiscal 2025 second quarter earnings announcement for Wednesday, May 7, 2025, before market opening. The earnings report will cover the quarter ended March 31, 2025.
The company will host a conference call and live webcast to discuss the financial results on May 7, 2025, at 8:30 a.m. Eastern Time. Investors, analysts, and media representatives can access the live webcast through Azenta's investor relations website. A replay of the event will be available starting May 8, 2025, at 8:30 a.m. ET.
Azenta (Nasdaq: AZTA) ha programmato l'annuncio dei risultati del secondo trimestre fiscale 2025 per mercoledì 7 maggio 2025, prima dell'apertura del mercato. Il rapporto finanziario riguarderà il trimestre conclusosi il 31 marzo 2025.
L'azienda terrà una conference call e una diretta webcast per discutere i risultati finanziari il 7 maggio 2025, alle 8:30 ora orientale. Investitori, analisti e rappresentanti dei media potranno accedere alla diretta webcast tramite il sito web delle relazioni con gli investitori di Azenta. Una replica dell'evento sarà disponibile a partire dall'8 maggio 2025, alle 8:30 ET.
Azenta (Nasdaq: AZTA) ha programado el anuncio de sus resultados del segundo trimestre fiscal 2025 para el miércoles 7 de mayo de 2025, antes de la apertura del mercado. El informe de ganancias cubrirá el trimestre finalizado el 31 de marzo de 2025.
La compañÃa realizará una llamada en conferencia y una transmisión en vivo para discutir los resultados financieros el 7 de mayo de 2025, a las 8:30 a.m. hora del Este. Inversionistas, analistas y representantes de medios podrán acceder a la transmisión en vivo a través del sitio web de relaciones con inversionistas de Azenta. Una repetición del evento estará disponible a partir del 8 de mayo de 2025, a las 8:30 a.m. ET.
Azenta (나스ë‹�: AZTA)ëŠ� 2025 íšŒê³„ì—°ë„ 2분기 실ì 발표ë¥� 2025ë…� 5ì›� 7ì� 수요ì�, 시장 개장 ì „ìœ¼ë¡� ì˜ˆì •í–ˆìŠµë‹ˆë‹¤. ì´ë²ˆ 실ì ë³´ê³ ì„œëŠ” 2025ë…� 3ì›� 31ì� 종료ë� 분기ë¥� 다룹니다.
회사ëŠ� 2025ë…� 5ì›� 7ì� ë™ë¶€ 표준ì‹� 기준 ì˜¤ì „ 8ì‹� 30ë¶�ì—� 재무 ê²°ê³¼ì—� 대í•� ë…¼ì˜í•˜ëŠ” 컨í¼ëŸ°ìФ 콜과 ë¼ì´ë¸� 웹ìºìŠ¤íŠ¸ë¥� ì§„í–‰í•� ì˜ˆì •ìž…ë‹ˆë‹�. 투ìžìž�, ì• ë„리스íŠ� ë°� ì–¸ë¡ ê´€ê³„ìžëŠ� Azentaì� 투ìžìž� ê´€ê³� 웹사ì´íЏë¥� 통해 ë¼ì´ë¸� 웹ìºìŠ¤íŠ¸ì—� ì ‘ì†í•� ìˆ� 있습니다. 행사ì� ìž¬ë°©ì†¡ì€ 2025ë…� 5ì›� 8ì� ì˜¤ì „ 8ì‹� 30ë¶�(ET)ë¶€í„� ì´ìš© 가능합니다.
Azenta (Nasdaq : AZTA) a programmé l'annonce de ses résultats du deuxième trimestre de l'exercice 2025 pour le mercredi 7 mai 2025, avant l'ouverture des marchés. Le rapport financier couvrira le trimestre clos au 31 mars 2025.
La société organisera une conférence téléphonique et une webdiffusion en direct pour discuter des résultats financiers le 7 mai 2025 à 8h30, heure de l'Est. Les investisseurs, analystes et représentants des médias pourront accéder à la webdiffusion en direct via le site des relations investisseurs d'Azenta. Un replay de l'événement sera disponible à partir du 8 mai 2025 à 8h30 ET.
Azenta (Nasdaq: AZTA) hat die Bekanntgabe der Ergebnisse für das zweite Quartal des Geschäftsjahres 2025 für Mittwoch, den 7. Mai 2025, vor Börsenbeginn geplant. Der Geschäftsbericht wird das Quartal zum 31. März 2025 abdecken.
Das Unternehmen wird am 7. Mai 2025 um 8:30 Uhr Eastern Time eine Telefonkonferenz und einen Live-Webcast veranstalten, um die Finanzergebnisse zu besprechen. Investoren, Analysten und Medienvertreter können den Live-Webcast über die Investor-Relations-Website von Azenta verfolgen. Eine Aufzeichnung der Veranstaltung wird ab dem 8. Mai 2025 um 8:30 Uhr ET verfügbar sein.
- None.
- None.
The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, May 7, 2025, at 8:30 a.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at . A replay will be available beginning at 8:30 a.m. ET on May 8, 2025.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit .
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial Planning & Analysis, and Investor Relations
[email protected]
Sherry Dinsmore
[email protected]
View original content to download multimedia:
SOURCE Azenta